Intech Investment Management LLC Increases Position in Astrana Health, Inc. (NASDAQ:ASTH)

Intech Investment Management LLC lifted its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 179.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 42,124 shares of the company’s stock after buying an additional 27,045 shares during the quarter. Intech Investment Management LLC’s holdings in Astrana Health were worth $1,328,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Handelsbanken Fonder AB lifted its stake in shares of Astrana Health by 4.7% during the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock valued at $281,000 after buying an additional 400 shares during the period. Swiss National Bank increased its position in Astrana Health by 1.1% during the fourth quarter. Swiss National Bank now owns 88,444 shares of the company’s stock worth $2,789,000 after purchasing an additional 1,000 shares during the last quarter. KBC Group NV acquired a new position in Astrana Health during the third quarter worth approximately $70,000. Quarry LP acquired a new position in Astrana Health during the third quarter worth approximately $77,000. Finally, Moran Wealth Management LLC increased its position in Astrana Health by 21.5% during the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock worth $250,000 after purchasing an additional 1,404 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ASTH shares. Stifel Nicolaus dropped their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Macquarie raised shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Bank of America dropped their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research report on Tuesday, March 4th. Robert W. Baird dropped their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, Truist Financial dropped their price objective on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research report on Tuesday. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $56.17.

Astrana Health Stock Performance

Astrana Health stock opened at $30.89 on Friday. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The company has a market capitalization of $1.74 billion, a price-to-earnings ratio of 23.76, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm’s fifty day moving average price is $33.97 and its 200 day moving average price is $42.56.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $665.21 million for the quarter, compared to analysts’ expectations of $617.24 million. On average, research analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.